Table of Content

1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Scope
1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Type
1.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016 & 2021 & 2027)
1.2.2 Salicylates
1.2.3 Propionic acid derivatives
1.2.4 Acetic acid derivatives
1.2.5 Enolic acid (Oxicam) derivatives
1.2.6 Anthranilic acid derivatives (Fenamates)
1.2.7 Selective COX-2 inhibitors (Coxibs)
1.2.8 Sulfonanilides
1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Application
1.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Human
1.3.3 Animals
1.3.4 Others
1.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Trends (2016-2027)

2 Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Forecasts by Region
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2016-2021)
2.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2016-2021)
2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2016-2027)
2.4.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2016-2027)
2.4.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2016-2027)
2.4.4 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2016-2027)
2.4.6 India Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2016-2027)

3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Competition Landscape by Players
3.1 Global Top Non-steroidal Anti-inflammatory Drugs (NSAID) Players by Sales (2016-2021)
3.2 Global Top Non-steroidal Anti-inflammatory Drugs (NSAID) Players by Revenue (2016-2021)
3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-steroidal Anti-inflammatory Drugs (NSAID) as of 2020)
3.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Company (2016-2021)
3.5 Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historic Market Review by Type (2016-2021)
4.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2021)
4.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2016-2021)
4.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2016-2021)
4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Type (2022-2027)
4.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Type (2022-2027)
4.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast by Type (2022-2027)

5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historic Market Review by Application (2016-2021)
5.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2021)
5.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2016-2021)
5.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2016-2021)
5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Application (2022-2027)
5.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Application (2022-2027)
5.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast by Application (2022-2027)

6 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures
6.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company
6.1.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company (2016-2021)
6.1.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021)
6.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type
6.2.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2016-2021)
6.2.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2022-2027)
6.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application
6.3.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application (2016-2021)
6.3.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application (2022-2027)

7 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures
7.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company
7.1.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company (2016-2021)
7.1.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021)
7.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type
7.2.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2022-2027)
7.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application
7.3.1 Europe 123 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 123 Sales Breakdown by Application (2022-2027)

8 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures
8.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company
8.1.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company (2016-2021)
8.1.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021)
8.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type
8.2.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2016-2021)
8.2.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2022-2027)
8.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application
8.3.1 China 143 Sales Breakdown by Application (2016-2021)
8.3.2 China 143 Sales Breakdown by Application (2022-2027)

9 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures
9.1 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company
9.1.1 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company (2016-2021)
9.1.2 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021)
9.2 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type
9.2.1 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2022-2027)
9.3 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures
10.1 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company
10.1.1 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company (2016-2021)
10.1.2 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021)
10.2 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type
10.2.1 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures
11.1 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company
11.1.1 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Company (2016-2021)
11.1.2 India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021)
11.2 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type
11.2.1 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2016-2021)
11.2.2 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Type (2022-2027)
11.3 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application
11.3.1 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application (2016-2021)
11.3.2 India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Non-steroidal Anti-inflammatory Drugs (NSAID) Business
12.1 Bayer
12.1.1 Bayer Corporation Information
12.1.2 Bayer Business Overview
12.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
12.1.5 Bayer Recent Development
12.2 Ecotrin
12.2.1 Ecotrin Corporation Information
12.2.2 Ecotrin Business Overview
12.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
12.2.5 Ecotrin Recent Development
12.3 Generic
12.3.1 Generic Corporation Information
12.3.2 Generic Business Overview
12.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
12.3.5 Generic Recent Development
12.4 St. Joseph
12.4.1 St. Joseph Corporation Information
12.4.2 St. Joseph Business Overview
12.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
12.4.5 St. Joseph Recent Development
12.5 Elanco
12.5.1 Elanco Corporation Information
12.5.2 Elanco Business Overview
12.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
12.5.5 Elanco Recent Development
12.6 Zoetis
12.6.1 Zoetis Corporation Information
12.6.2 Zoetis Business Overview
12.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
12.6.5 Zoetis Recent Development
12.7 Boehringer Ingelheim
12.7.1 Boehringer Ingelheim Corporation Information
12.7.2 Boehringer Ingelheim Business Overview
12.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
12.7.5 Boehringer Ingelheim Recent Development
12.8 Merial
12.8.1 Merial Corporation Information
12.8.2 Merial Business Overview
12.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
12.8.5 Merial Recent Development
12.9 Merck Animal Health
12.9.1 Merck Animal Health Corporation Information
12.9.2 Merck Animal Health Business Overview
12.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
12.9.5 Merck Animal Health Recent Development

13 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Cost Analysis
13.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)
13.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List
14.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Customers

15 Market Dynamics
15.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trends
15.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Drivers
15.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
15.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Region (2016-2021)
Table 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2016-2021)
Table 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Region (2016-2021)
Table 8. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Company (2016-2021)
Table 14. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Company (2016-2021)
Table 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-steroidal Anti-inflammatory Drugs (NSAID) as of 2020)
Table 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Sites and Area Served
Table 19. Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Type (2016-2021)
Table 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2016-2021)
Table 23. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Type (2016-2021)
Table 25. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2022-2027)
Table 26. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2022-2027)
Table 28. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Type (2022-2027)
Table 29. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Application (2016-2021)
Table 30. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Application (2016-2021)
Table 31. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Application (2016-2021)
Table 33. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Application (2022-2027)
Table 34. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Application (2022-2027)
Table 35. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Application (2022-2027)
Table 37. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Application (2022-2027)
Table 38. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Company (2016-2021)
Table 39. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Company (2016-2021)
Table 40. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Company (2016-2021)
Table 42. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2021) & (K Units)
Table 43. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2021)
Table 44. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2022-2027) & (K Units)
Table 45. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2022-2027)
Table 46. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2021) & (K Units)
Table 47. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2021)
Table 48. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2022-2027) & (K Units)
Table 49. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2022-2027)
Table 50. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Company (2016-2021)
Table 51. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Company (2016-2021)
Table 52. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Company (2016-2021)
Table 54. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2021) & (K Units)
Table 55. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2021)
Table 56. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2022-2027) & (K Units)
Table 57. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2022-2027)
Table 58. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2021) & (K Units)
Table 59. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2021)
Table 60. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2022-2027) & (K Units)
Table 61. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2022-2027)
Table 62. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Company (2016-2021)
Table 63. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Company (2016-2021)
Table 64. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Company (2016-2021)
Table 66. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2021) & (K Units)
Table 67. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2021)
Table 68. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2022-2027) & (K Units)
Table 69. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2022-2027)
Table 70. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2021) & (K Units)
Table 71. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2021)
Table 72. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2022-2027) & (K Units)
Table 73. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2022-2027)
Table 74. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Company (2016-2021)
Table 75. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Company (2016-2021)
Table 76. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Company (2016-2021)
Table 78. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2021) & (K Units)
Table 79. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2021)
Table 80. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2022-2027) & (K Units)
Table 81. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2022-2027)
Table 82. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2021) & (K Units)
Table 83. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2021)
Table 84. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2022-2027) & (K Units)
Table 85. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2022-2027)
Table 98. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Company (2016-2021)
Table 99. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Company (2016-2021)
Table 100. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Company (2016-2021)
Table 102. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2021) & (K Units)
Table 103. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2021)
Table 104. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2022-2027) & (K Units)
Table 105. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2022-2027)
Table 106. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2021) & (K Units)
Table 107. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2021)
Table 108. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2022-2027) & (K Units)
Table 109. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2022-2027)
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Business Overview
Table 112. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 114. Bayer Recent Development
Table 115. Ecotrin Corporation Information
Table 116. Ecotrin Description and Business Overview
Table 117. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 119. Ecotrin Recent Development
Table 120. Generic Corporation Information
Table 121. Generic Description and Business Overview
Table 122. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 124. Generic Recent Development
Table 125. St. Joseph Corporation Information
Table 126. St. Joseph Description and Business Overview
Table 127. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 129. St. Joseph Recent Development
Table 130. Elanco Corporation Information
Table 131. Elanco Description and Business Overview
Table 132. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 134. Elanco Recent Development
Table 135. Zoetis Corporation Information
Table 136. Zoetis Description and Business Overview
Table 137. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 139. Zoetis Recent Development
Table 140. Boehringer Ingelheim Corporation Information
Table 141. Boehringer Ingelheim Description and Business Overview
Table 142. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 144. Boehringer Ingelheim Recent Development
Table 145. Merial Corporation Information
Table 146. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Merial Description and Business Overview
Table 148. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 149. Merial Recent Development
Table 150. Merck Animal Health Corporation Information
Table 151. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Merck Animal Health Description and Business Overview
Table 153. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 154. Merck Animal Health Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List
Table 158. Non-steroidal Anti-inflammatory Drugs (NSAID) Customers List
Table 159. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trends
Table 160. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
Table 161. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
Table 162. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Product Picture
Figure 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type in 2021 & 2027
Figure 3. Salicylates Product Picture
Figure 4. Propionic acid derivatives Product Picture
Figure 5. Acetic acid derivatives Product Picture
Figure 6. Enolic acid (Oxicam) derivatives Product Picture
Figure 7. Anthranilic acid derivatives (Fenamates) Product Picture
Figure 8. Selective COX-2 inhibitors (Coxibs) Product Picture
Figure 9. Sulfonanilides Product Picture
Figure 10. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application in 2021 & 2027
Figure 11. Human Examples
Figure 12. Animals Examples
Figure 13. Others Examples
Figure 14. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) Growth Rate (2016-2027)
Figure 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region: 2016 VS 2021
Figure 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region: 2021 VS 2027
Figure 20. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) Growth Rate (2016-2027)
Figure 22. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (Million USD) Growth Rate (2016-2027)
Figure 24. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (Million USD) and Growth Rate (2016-2027)
Figure 26. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (Million USD) Growth Rate (2016-2027)
Figure 30. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (Million USD) Growth Rate (2016-2027)
Figure 32. Global 5 Largest Non-steroidal Anti-inflammatory Drugs (NSAID) Players Market Share by Revenue in Non-steroidal Anti-inflammatory Drugs (NSAID): 2016 & 2020
Figure 33. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 34. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2016-2021)
Figure 35. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate by Type in 2016 & 2020
Figure 36. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Application (2016-2021)
Figure 37. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type in 2020
Figure 39. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application in 2020
Figure 40. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type in 2020
Figure 41. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application in 2020
Figure 42. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type in 2020
Figure 43. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application in 2020
Figure 44. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type in 2020
Figure 45. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application in 2020
Figure 46. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type in 2020
Figure 47. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application in 2020
Figure 48. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type in 2020
Figure 49. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application in 2020
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure 52. Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure 53. Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed